Trulieve Cannabis Statistics
Total Valuation
Trulieve Cannabis has a market cap or net worth of 914.39 million. The enterprise value is 1.39 billion.
| Market Cap | 914.39M |
| Enterprise Value | 1.39B |
Important Dates
The next estimated earnings date is Friday, February 28, 2025.
| Earnings Date | Feb 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.37% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 149.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.62, with an EV/FCF ratio of 4.89.
| EV / Earnings | -10.76 |
| EV / Sales | 1.26 |
| EV / EBITDA | 4.62 |
| EV / EBIT | 12.06 |
| EV / FCF | 4.89 |
Financial Position
The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.63.
| Current Ratio | 4.41 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 2.58 |
| Debt / FCF | 2.91 |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is -9.53% and return on invested capital (ROIC) is 3.42%.
| Return on Equity (ROE) | -9.53% |
| Return on Assets (ROA) | 2.71% |
| Return on Capital (ROIC) | 3.42% |
| Revenue Per Employee | 217,096 |
| Profits Per Employee | -23,843 |
| Employee Count | 5,400 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.42% in the last 52 weeks. The beta is 1.43, so Trulieve Cannabis's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | -4.42% |
| 50-Day Moving Average | 7.76 |
| 200-Day Moving Average | 9.92 |
| Relative Strength Index (RSI) | 34.41 |
| Average Volume (20 Days) | 535,456 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Trulieve Cannabis had revenue of 1.17 billion and -128.75 million in losses. Loss per share was -0.68.
| Revenue | 1.17B |
| Gross Profit | 682.58M |
| Operating Income | 122.41M |
| Pretax Income | 64.44M |
| Net Income | -128.75M |
| EBITDA | 288.32M |
| EBIT | 122.41M |
| Loss Per Share | -0.68 |
Balance Sheet
The company has 317.85 million in cash and 823.24 million in debt, giving a net cash position of -505.40 million.
| Cash & Cash Equivalents | 317.85M |
| Total Debt | 823.24M |
| Net Cash | -505.40M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 6.94 |
| Working Capital | 466.32M |
Cash Flow
In the last 12 months, operating cash flow was 372.37 million and capital expenditures -89.29 million, giving a free cash flow of 283.08 million.
| Operating Cash Flow | 372.37M |
| Capital Expenditures | -89.29M |
| Free Cash Flow | 283.08M |
| FCF Per Share | n/a |
Margins
Gross margin is 58.22%, with operating and profit margins of 10.44% and -10.98%.
| Gross Margin | 58.22% |
| Operating Margin | 10.44% |
| Pretax Margin | 5.50% |
| Profit Margin | -10.98% |
| EBITDA Margin | 24.59% |
| EBIT Margin | 10.44% |
| FCF Margin | 24.15% |
Dividends & Yields
Trulieve Cannabis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.37% |
| Shareholder Yield | -0.37% |
| Earnings Yield | -14.00% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Trulieve Cannabis has an Altman Z-Score of 1.02. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.02 |
| Piotroski F-Score | n/a |